Carbohydrates as scaffolds in drug discovery.
Wim Meutermans, Giang Thanh Le, Bernd Becker
Index: ChemMedChem 1(11) , 1164-69, (2006)
Full Text: HTML
Abstract
Drug discovery has long suffered from the difficulty of having to place pharmacophoric groups in just the right spatial arrangement to elicit the desired biological response. Although some molecule classes have been discovered that seem to be privileged structures for at least some drug-receptor interactions, there remains the challenge to design and synthesize molecules with high specific affinity to pharmacologically important targets. With their high density of stereochemical information and their relative rigidity, carbohydrates provide excellent platforms upon which to display a number of substituents in a sterically defined way, hence offering the opportunity to harness their unique features for the drug-discovery process. This review highlights the progress that has been made in the development of carbohydrate scaffolds for drug discovery.
Related Compounds
Related Articles:
MCC/SN Ar methodology. Part 2: Novel three-step solution phase access to libraries of benzodiazepines. Tempest P, et al.
[Tetrahedron Lett. 44(9) , 1947-50, (2003)]
Solid support synthesis of 2-substituted dibenz [b, f] oxazepin-11 (10H)-ones< i> via</i> S< sub> N</sub> Ar methodology on AMEBA resin. Ouyang X, et al.
[Tetrahedron 55(10) , 2827-34, (1999)]
Efficient approach for the diversity-oriented synthesis of macro-heterocycles on solid-support. Giulianotti M and Nefzi A.
[Tetrahedron Lett. 44(28) , 5307-9, (2003)]